Influence of health providers on pediatrics' immunization rate

Omer Q B Al-lela1, Mohd Baidi Bahari, Mustafa G Al-abbassi

  • 1School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia. omarallela@yahoo.com

Insights

Childhood immunization rates are significantly influenced by provider type and birthplace. Understanding these factors is crucial for improving vaccination coverage in young children.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood immunization is critical for preventing infectious diseases.
  • Suboptimal immunization rates remain a challenge in many regions, including Iraq.
  • Identifying factors associated with immunization coverage is essential for targeted interventions.

Purpose of the Study:

  • To determine characteristics of immunization providers linked to vaccination rates in children under two years.
  • To explore risk factors for partial immunization in young children.

Main Methods:

  • A cohort and cluster sampling design was employed.
  • Data were collected from 528 children aged 18–70 months across five public health clinics in Mosul, Iraq.
  • Bivariate analyses and multi-level logistic regression models were used to analyze provider characteristics and immunization status.

Main Results:

  • Less than half of the children studied experienced missed vaccination doses, classifying them as partially immunized.
  • A significant association was found between immunization rates and the type of immunization provider.
  • Child's birthplace and the type of immunization provider were identified as key factors impacting immunization rates, even when controlling for other variables.

Conclusions:

  • Provider type and birthplace are significant determinants of childhood immunization rates.
  • Interventions aimed at improving childhood vaccination coverage should consider these identified provider and demographic factors.
  • Further research into optimizing public health clinic strategies in Mosul, Iraq, is warranted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...